Parameters | CKD (n = 42) | CKD (n = 360) | p value | Overall |
Use of Cotrimoxazole | ||||
Yes | 42.9% (18) | 39.4% (142) | 0.669 | 39.8% (160) |
No | 57.1% (24) | 60.6% (218) |
| 60.2% (200) |
Antiretroviral therapy | ||||
First line | 97.6% (41) | 93.1% (335) | 0.2552 | 93.5% (376) |
Second line | 2.4% (1) | 6.9% (25) |
| 6.5% (26) |
Duration of the treatment | ||||
Less than 2 years | 0% (0) | 1.3% (5) | 1 | 1.2% (5) |
2 to 5 years | 16.3% (7) | 26.7% (96) | 0.1419 | 25.6% (103) |
Over 5 years | 83.7% (35) | 72% (259) | 0.1019 | 73.2% (294) |